Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1397 CDR404, an antibody-based bispecific & bivalent T-cell engager targeted against MAGE-A4, for Squamous Non-Small Cell Lung Cancer (SQ-NSCLC)
Compose a Response to This Article
Other responses
No responses have been published for this article.
